Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies

Journal of Immunology

Volumn 179, Issue 11, 2007, Pages 7959-7966

  Frisoni, Lorenza ^a   McPhie, Lenese ^a   Kang, Sun Ah ^b   Monestier, Marc ^b   Madaio, Michael ^b   Satoh, Minoru ^c   Caricchio, Roberto ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CASPASE ACTIVATED DEOXYRIBONUCLEASE; ENDONUCLEASE; DEOXYRIBONUCLEASE; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDE; PHOSPHOLIPID; PRISTANE; TERPENE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CHROMATIN; CONTROLLED STUDY; CYTOPLASM; FRAGMENTATION REACTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IN VIVO STUDY; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; AUTOIMMUNE DISEASE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DNA FRAGMENTATION; DRUG EFFECT; GAMMA RADIATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; RADIATION EXPOSURE;

ANIMALS; ANTIBODIES, ANTINUCLEAR; APOPTOSIS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CHROMATIN; DEOXYRIBONUCLEASES; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; GAMMA RAYS; IMMUNOGLOBULIN G; LIPOPOLYSACCHARIDES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPIDS; TERPENES;

EID: 38849162227     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.11.7959     Document Type: Article

References (47)

1. Casciola-Rosen, L. A., G. Anhalt, and A. Rosen. 1994. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179: 1317-1330.
2. Mevorach, D., J. L. Zhou, X. Song, and K. B. Elkon. 1998. Systemic exposure to irradiated apoptotic cells induces autoantibody production. J. Exp. Med. 188: 387-392.
3. Cohen, P. L., R. Caricchio, V. Abraham, T. D. Camenisch, J. C. Jennette, R. A. Roubey, H. S. Earp, G. Matsushima, and E. A. Reap. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 196: 135-140.
4. Korb, L. C., and J. M. Ahearn. 1997. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158: 4525-4528.
5. Bickerstaff, M. C., M. Botto, W. L. Hutchinson, J. Herbert, G. A. Tennent, A. Bybee, D. A. Mitchell, H. T. Cook, P. J. Butler, M. J. Walport, and M. B. Pepys. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5: 694-697.
6. Napirei, M., H. Karsunky, B. Zevnik, H. Stephan, H. G. Mannherz, and T. Moroy. 2000. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat. Genet. 25: 177-181.
7. Gensler, T. J., M. Hottelet, C. Zhang, S. Schlossman, P. Anderson, and P. J. Utz. 2001. Monoclonal antibodies derived from BALB/c mice immunized with apoptotic Jurkat T cells recognize known autoantigens. J. Autoimmun. 16: 59-69.
8. Baumann, I., W. Kolowos, R. E. Voll, B. Manger, U. Gaipl, W. L. Neuhuber, T. Kirchner, J. R. Kalden, and M. Herrmann. 2002. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 46: 191-201.
9. Caricchio, R., L. Mcphie, and P. Cohen. 2003. UV-B radiation-induce cell death: critical role of UV dose in inflammation and lupus autoantigen redistribution. J. Immunol. 171: 5778-5786.
10. Pisetsky, D. S. 2004. DNA as a marker of cell death in systemic lupus erythematosus. Rheum. Dis. Clin. N. Am. 30: 575-587, x.
11. Wyllie, A. H., J. F. Kerr, and A. R. Currie. 1980. Cell death: the significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
12. Sakahira, H., M. Enari, Y. Ohsawa, Y. Uchiyama, and S. Nagata. 1999. Apoptotic nuclear morphological change without DNA fragmentation. Curr. Biol. 9: 543-546.
13. Frisoni, L., L. McPhie, L. Colonna, U. Sriram, M. Monestier, S. Gallucci, and R. Caricchio. 2005. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity? J. Immunol. 175: 2692-2701.
14. Amoura, Z., S. Koutouzov, and J. C. Piette. 2000. The role of nucleosomes in lupus. Curr. Opin. Rheumatol. 12: 369-373.
15. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
16. Boule, M. W., C. Broughton, F. Mackay, S. Akira, A. Marshak-Rothstein, and I. R. Rifkin. 2004. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199: 1631-1640.
17. Enari, M., H. Sakahira, H. Yokoyama, K. Okawa, A. Iwamatsu, and S. Nagata. 1998. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50.
18. Kawane, K., H. Fukuyama, H. Yoshida, H. Nagase, Y. Ohsawa, Y. Uchiyama, K. Okada, T. Iida, and S. Nagata. 2003. Impaired thymic development in mouse embryos deficient in apoptotic DNA degradation. Nat. Immunol. 4: 138-144.
19. Nagata, S., H. Nagase, K. Kawane, N. Mukae, and H. Fukuyama. 2003. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 10: 108-116.
20. Zhang, J., X. Wang, K. E. Bove, and M. Xu. 1999. DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells. J. Biol. Chem. 274: 37450-37454.
21. McIlroy, D., H. Sakahira, R. V. Talanian, and S. Nagata. 1999. Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene 18: 4401-4408.
22. Satoh, M., and W. H. Reeves. 1994. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180: 2341-2346.
23. Satoh, M., A. Kumar, Y. S. Kanwar, and W. H. Reeves. 1995. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA 92: 10934-10938.
24. Calvani, N., R. Caricchio, M. Tucci, E. S. Sobel, F. Silvestris, P. Tartaglia, and H. B. Richards. 2005. Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J. Immunol. 175: 4777-4782.
25. Nicolo, D., B. I. Goldman, and M. Monestier. 2003. Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody. Arthritis Rheum. 48: 2974-2978.
26. Rodriguez, I., K. Matsuura, C. Ody, S. Nagata, and P. Vassalli. 1996. Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J. Exp. Med. 184: 2067-2072.
27. Reap, E. A., D. Leslie, M. Abrahams, R. A. Eisenberg, and P. L. Cohen. 1995. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice. J. Immunol. 154: 936-943.
28. Caricchio, R., D. Kovalenko, W. K. Kaufmann, and P. L. Cohen. 1999. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system. Clin. Immunol. 93: 65-74.
29. Racke, M. K. 2001. Experimental Autoimmune Encephalomyelitis (EAE). John Wiley and Sons, Inc, New York.
30. Chan, O. T., M. P. Madaio, and M. J. Shlomchik. 1999. B cells are required for lupus nephritis in the polygenic: Fas-intact MRL model of systemic autoimmunity. J. Immunol. 163: 3592-3596.
31. Chan, O., M. P. Madaio, and M. J. Shlomchik. 1997. The roles of B cells in MRL/lpr murine lupus. Ann. NY Acad. Sci. 815: 75-87.
32. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
33. Caricchio, R., E. A. Reap, and P. L. Cohen. 1998. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis. J. Immunol. 161: 241-251.
34. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182: 1545-1556.
35. McIlroy, D., M. Tanaka, H. Sakahira, H. Fukuyama, M. Suzuki, K. Yamamura, Y. Ohsawa, Y. Uchiyama, and S. Nagata. 2000. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev. 14: 549-558.
36. Fadok, V. A., and G. Chimini. 2001. The phagocytosis of apoptotic cells. Semin. Immunol. 13: 365-372.
37. Casciola-Rosen, L., D. W. Nicholson, T. Chong, K. R. Rowan, N. A. Thornberry, D. K. Miller, and A. Rosen. 1996. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183: 1957-1964.
38. Gold, R., C. Linington, and H. Lassmann. 2006. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
39. Hamilton, K. J., M. Satoh, J. Swartz, H. B. Richards, and W. H. Reeves. 1998. Influence of microbial stimulation on hypergammaglobulinemia and autoantibody production in pristane-induced lupus. Clin. Immunol. Immunopathol. 86: 271-279.
40. Naim, J. O., M. Satoh, N. A. Buehner, K. M. Ippolito, H. Yoshida, D. Nusz, L. Kurtelawicz, S. F. Cramer, and W. H. Reeves. 2000. Induction of hypergammaglobulinemia and macrophage activation by silicone gels and oils in female A.SW mice. Clin. Diagn. Lab. Immunol. 7: 366-370.
41. Sekiguchi, D. R., S. M. Jainandunsing, M. L. Fields, M. A. Maldonado, M. P. Madaio, J. Erikson, M. Weigert, and R. A. Eisenberg. 2002. Chronic graft-versus-host in Ig knockin transgenic mice abrogates B cell tolerance in antidouble-stranded DNA B cells. J. Immunol. 168: 4142-4153.
42. Nagata, S. 2005. DNA degradation in development and programmed cell death. Annu. Rev. Immunol. 23: 853-875.
43. Kuroda, Y., D. C. Nacionales, J. Akaogi, W. H. Reeves, and M. Satoh. 2004. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed. Pharmacother. 58: 325-337.
44. Christensen, S. R., J. Shupe, K. Nickerson, M. Kashgarian, R. A. Flavell, and M. J. Shlomchik. 2006. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25: 417-428.
45. Christensen, S. R., M. Kashgarian, L. Alexopoulou, R. A. Flavell, S. Akira, and M. J. Shlomchik. 2005. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202: 321-331.
46. Hanayama, R., M. Tanaka, K. Miyasaka, K. Aozasa, M. Koike, Y. Uchiyama, and S. Nagata. 2004. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147-1150.
47. Denny, M. F., P. Chandaroy, P. D. Killen, R. Caricchio, E. E. Lewis, B. C. Richardson, K. D. Lee, J. Gavalchin, and M. J. Kaplan. 2006. Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. J. Immunol. 176: 2095-2104.